Pleurisy Market Trends, Growing Demand, Synopsis, Opportunities and Analysis 2022 to 2030
Market Highlights
There are wide market for pleurisy globally owing to
increasing prevalence of chronic disease such as lung cancer, heart surgery,
pancreatitis, chest trauma, autoimmune disorder, and asbestosis globally. These
disease are consider as the leading causes for pleurisy. According to World
Health Organization (WHO), in 2016, more than 90% of Chronic Obstructive
Pulmonary Disease (COPD) deaths occur in the low and middle-income countries,
also the Global Burden of Disease Study reports a prevalence of 251 million
cases of COPD globally in 2016. Report suggest that the primary cause of COPD
is exposure to tobacco smoke. These rising number in population suffering with
COPD generating the huge demand for better treatment.
According to a report published by British Society for
Rheumatology, in 2016, Rheumatoid arthritis affects roughly 700,000 people in
the U.K, and at least 115,000 people in the U.K live with Crohn’s disease
Increasing prevalence of chronic disease, rising demand for
better treatment, increasing investment in research and development, and
availability of funds drive the growth of the market. Moreover, increasing
government support, changing lifestyle, and rapidly developing technology is
expected to fuel the market growth during the forecast period. However, high
cost of the treatment may slow the market growth during the period 2017-2023.
The Pleurisy
market is anticipated to reach USD 3,153.3 Million by 2030 at 6.8%
CAGR during the forecast period 2022-2030.
Pleurisy, a condition characterized by inflammation of the
pleura, the thin membranes that line the chest cavity and surround the lungs,
can be a painful and debilitating condition. It can result from various
underlying causes, such as infections, autoimmune diseases, or traumatic
injuries. The Pleurisy market, encompassing diagnostics, therapeutics, and
research, has seen notable developments in recent years. This article explores
the current state of the Pleurisy market, including advances, challenges, and
future prospects.
Key Players
Some of the key players in this market are: Scanlan
International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc.
(U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan),
Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas)
and others.
Regional Analysis
The Americas dominate the global pleurisy market owing to
the presence of huge patient population with chronic diseases, and increasing
government support for research & development. Furthermore, market players
of this region continue to be involved in providing quality products which give
an edge to this region in global leader.
Europe holds the second largest share of the global pleurisy
market as result of increasing focus of various government agencies on the
treatment of chronic diseases. Moreover, the growing public awareness about
healthcare is likely to boost the European market.
Asia Pacific is the fastest growing pleurisy market across
the globe. Japan holds a major share of the regional market due to availability
of advanced technology and huge healthcare spending. Moreover, rapidly
developing economy, increasing healthcare expenditure, and the government’s
initiatives for research & development is projected to drive the market in
China and India over the forecast period.
The Middle East and Africa holds the least share of the
global market due to limited availability of medical facilities. The UAE, Saudi
Arabia, and Kuwait are expected to drive the Middle East & African market.
Whereas, the African region is expected to witness a moderate growth.
Segmentation
The global pleurisy market is segmented on the basis of
diagnosis devices, treatment, and by end user. On the basis of the diagnosis
devices, it is segmented into thoracentesis, video-assisted thoracic surgery,
imaging devices, blood test, and others. Furthermore, imaging devices are
segmented into the computed tomography, magnetic resonance imaging, ultrasound,
and others. On the basis of the treatment, it is segmented into antibiotics,
antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others.
On the basis of end user, it is segmented into hospital, clinics, diagnostics
laboratories, and others.
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment